Tuesday, 11 May 2021 04:38 PM MYT
BY JERRY CHOONG
Health Minister Datuk Seri Dr Adham Baba receiving the Sinovac vaccines from Pharmaniaga Bhd managing director Datuk Zulkarnain Md Eusope in Putrajaya, May 11, 2021. Bernama pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, May 11 Pharmaniaga Berhad subsidiary Pharmaniaga LifeScience Sdn Bhd (PLS) has submitted the first four batches of the Sinovac vaccine it completed with the fill and finish process in Malaysia.
Astro Awani reported Health Minister Datuk Seri Dr Adham Baba as saying the batches were produced from May 1 to May 5.
“The batches were produced for the validation process and the Good Manufacturing Practice unit of the National Pharmaceutical Regulatory Agency. As of today, 1.28 million vials have been produced for this month,” he said following the handover ceremony for the vaccine by Pharmaniaga in Putrajaya.
PUTRAJAYA: Malaysia’s Covid-19 cases remain above the 2,000 mark, with more than half of the infections recorded in Selangor and Sarawak.
In his daily Covid-19 updates, Health director-general Tan Sri Dr Noor Hisham said there were 2,847 new cases in the country, bringing the cumulative total to 387,535.
“Selangor recorded the highest daily figure with 748 cases or 26.3% of the country’s cases.
“At least 80.5% of the cases in the state were uncovered from clusters and contact tracing activities.
“This is followed by Sarawak with 717 cases or 25.2%, and Kelantan with 476 cases (16.7%), ” said Dr Noor Hisham.
Other places recording three digits in their daily figure were Kuala Lumpur (302), Johor (130 new cases) and Negri Sembilan (105)
DCA approves Pharmaniaga-produced Sinovac vaccine
Published
Modified10:20 am
-
The Drug Control Authority (DCA) has approved the Sinovac vaccine that has been filled-and-finished by local drugmaker Pharmaniaga LifeScience Sdn Bhd (PLS).
This is the second source of Sinovac’s CononaVac vaccine to receive conditional approval for use in Malaysia, the other being finished doses produced by Sinovac itself in China.
“PLS’ fill-and-finish of CoronaVac is a.
All Access Plan
Friday, 23 Apr 2021 06:58 PM MYT
Health director-general Tan Sri Dr Noor Hisham Abdullah said this was the first time that the product, produced by Pharmaniaga LifeScience Sdn Bhd (PLS) through ‘fill-and-finish’ manufacturing, was being implemented in the country. Picture by Miera Zulyana
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, April 23 The 356th Drug Control Authority (DCA) meeting today agreed to approve the conditional registration for the CoronaVac Suspension for Injection Covid-19 Vaccine (Vero Cell), Inactivated for use during disasters.
Health director-general Tan Sri Dr Noor Hisham Abdullah said this was the first time that the product, produced by Pharmaniaga LifeScience Sdn Bhd (PLS) through “fill-and-finish” manufacturing, was being implemented in the country.
Covid-19: Malaysia approves conditional registration for China s CoronaVac vaccine thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.